NeuroPace, Inc. (NPCE): Price and Financial Metrics Recent IPO
GET POWR RATINGS... FREE!
NPCE Stock Price Chart Interactive Chart >
NPCE Price/Volume Stats
|Current price||$17.42||52-week high||$27.38|
|Prev. close||$17.75||52-week low||$17.02|
|Day high||$17.79||Avg. volume||106,502|
|50-day MA||$21.61||Dividend yield||N/A|
|200-day MA||$0.00||Market Cap||423.24M|
NeuroPace, Inc. (NPCE) Company Bio
NeuroPace, Inc. operates as a medical device company in the United States. The company develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. Its RNS system also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.
Most Popular Stories View All
NPCE Latest News Stream
|Loading, please wait...|
NPCE Latest Social Stream
View Full NPCE Social Stream
Latest NPCE News From Around the Web
Below are the latest news stories about NeuroPace Inc that investors may wish to consider to help them evaluate NPCE as an investment opportunity.
Global Artificial Neuroprosthetics Market 2021 Study Analysis: Rising Applications in Various Industries Boost the industry 2028| Cochlear, Abbott, Neuropace, Medtronic, Boston Scientific, Sonova
Report Title Artificial Neuroprosthetics Market is one of the most comprehensive and important additions to the QY Reports. Provides detailed research and analysis of key aspects of the global Artificial Neuroprosthetics market. Market analysts write in-depth information provided in this
Implantable Neurostimulation Devices Market Covering Growth Elements and Future Trends by 2027, Players - LivaNova, Nevro, NeuroPace, Beijing Pins, Synapse Biomedical, St. Jude Medical (Abbott)
The Implantable Neurostimulation Devices Market is expected to grow at a CAGR of 6.1 % and is poised to reach $XX Billion by 2027 as compared to $XX Billion in 2020 The research report on the Implantable Neurostimulation Devices Market fabricated
Vagus Nerve Stimulators Market Anticipated to Observe the Maximum Growth During the Forecast Period, Players -Medtronic PLC LivaNova, PLC Neuropace Inc
New York, United States :The Research specialists at Decisive Markets Insights have crafted a brand-new report on the Vagus Nerve Stimulators MARKET market which will elucidate a 360-degree overview of the global market post-COVID-19 pandemic. Also, it will inculcate detailed
MOUNTAIN VIEW, Calif., Aug. 23, 2021 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy, today reported that the company will be participating in three upcoming conferences.
Joining me from NeuroPace are Mike Favet, CEO; and Rebecca Kuhn, CFO. Earlier today, NeuroPace released financial results for the quarter ended June 30, 2021. Before we begin, I'd like to remind you that management will make statements during this call that will include forward-looking statements within the meaning of federal securities laws, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.
NPCE Price Returns